Nutriband Inc.NTRB

$2.90-0.16 (-5.23%)

NASDAQHealthcare24:00 UTC

Company snapshot

Market Cap

$35M

Micro-cap

-13%

2021 — today

10-Year Price

-38%

2021 — today

52-Week Range

$2.90$10.72

Current $2.90· 0%

Nutriband Inc. specializes in developing a diverse range of pharmaceutical products delivered via transdermal patches. The company's most advanced program centers on AVERSA fentanyl, an innovative fentanyl transdermal system engineered to prevent abuse. This extended-release patch provides healthcare professionals and patients with a continuous opioid therapy solution for the ongoing management of chronic pain. Its development pipeline also includes other treatments, such as AVERSA buprenorphine and AVERSA methylphenidate. Additionally, Nutriband is working on exenatide for individuals with type 2 diabetes and follicle stimulating hormone as a treatment for infertility. The company also holds a licensing agreement with Rambam Med-Tech Ltd. to further the development of RAMBAM Closed System Transfer Devices. Nutriband Inc. was founded in 2016 and its main offices are located in Orlando, Florida.

Valuation in context

P/E ratio

-1.1

N/A

Not meaningful — company is unprofitable

P/B ratio

5.9

Above average

Pricier than usual over the last 10 years

FCF Yield

-12.4%

Historically low

Historically low relative to the last 10 years

Free · No credit card needed

Get alerted when NTRB is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.